The presence of abnormal cells with malignant potential or neoplastic characteristics is a relatively common phenomenon. The interaction of these abnormal cells with their microenvironment is essential for tumor development, protection from the body's immune or defence mechanisms, later progression and the development of life-threatening or metastatic disease. The tumor microenvironment is a collective term…
Cancer Growth and Metastasis Template
Write in a clean editor, then format for Cancer Growth and Metastasis in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Cancer Growth and Metastasis format
Cancer Growth and Metastasis is a peer-reviewed journal published by SAGE, covering Cancer Cells and Metastasis, Bone health and treatments, Peptidase Inhibition and Analysis.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Cancer Growth and Metastasis, 12(3), pp. 45–58.
Formats any DOI in Cancer Growth and Metastasis style. No sign-up. |
| Publishes research in | Cancer Cells and Metastasis Bone health and treatments Peptidase Inhibition and Analysis Cell Adhesion Molecules Research Immune cells in cancer |
| ISSN | 1179-0644 |
| h-index | 27 |
| i10-index | 39 |
| Total citations | 2,199 |
| Open access | Yes |
| Top institutions publishing here | University of Arizona |
| Journal website | insights.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Cancer Growth and Metastasis per year
Citation impact of Cancer Growth and Metastasis by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Cancer Growth and Metastasis
Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM). More than 80% of MM patients suffer from destructive bony lesions, leading to pain, fractures, mobility issues, and neurological deficits. MBD is not only a main cause of disability and morbidity in MM patients but also increases the cost of management. Bone destruction…
BACKGROUND: Metastatic cells from a primary tumor can occur before the primary cancer is detected. Metastatic cells can also remain in the patient for many years after removal of the primary tumor without proliferating. These dormant malignant cells can awaken and cause recurrent disease decades after the primary treatment. The purpose of this article is…
In addition to inducing lethal DNA damage in tumor and stromal cells, radiation can alter the interactions of tumor cells with their microenvironment. Recent technological advances in planning and delivery of external beam radiotherapy have allowed delivery of larger doses per fraction (hypofractionation) while minimizing dose to normal tissues with higher precision. The effects of…
The relationship between wound healing and cancer has long been recognized. The mechanisms that regulate wound healing have been shown to promote transformation and growth of malignant cells. In addition, chronic inflammation has been associated with malignant transformation in many tissues. Recently, pathways involved in inflammation and wound healing have been reported to enhance cancer…